Now that the potential for harnessing the immune system to attack cancer has been well validated, drug makers are looking to the next big therapy area in which to explore the power of the immune system. One area that is getting attention, based on encouraging preclinical data, is neurodegenerative disease.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?